STAT July 22, 2025
BC 007, a German infusion that had lifted hope of patients, is heading for new study
This article is published in collaboration with The Sick Times, an online publication covering long Covid.
The clinical trial changed Shayna Bhalla’s life.
After years with long Covid — debilitated by fatigue, headaches, and neurological issues — her symptoms dramatically receded. While not fully back to her pre-Covid-19 baseline, she was able to resume university classes and other daily activities.
“In the last few months, I have literally regained life,” Bhalla said in an interview last November.
Bhalla posted on social media about her experience, garnering attention from other people with long Covid who hoped they could benefit from the same drug: an infusion...
Today's Sponsors
Today's Sponsor